Upload Avatar (500 x 500)
Jie Li
Medical School
Nanjing University
Jiangsu
Language: English, Chinese
Fatty Liver Disease: Liver
Steatosis
Nafld
Nash
Metabolism
Inflammation
Fibrosis
Hepatology
Lipids
Obesity
Viral Hepatitis: Hbv
Hcv
Liver
Infection
Cirrhosis
Antiviral
Immune Response
Chronic
Areas of Focus
- Fatty Liver Disease
- Viral Hepatitis
Academic Background & Achievements
- 2011 - PhD in Internal Medicine: Zhejiang University
- 2015 - Zheng Yu Tung Doctoral Scholarship: University of Hong Kong
- 2016 - Research on Fatty Liver Disease Mechanism: Stanford University
Publications
- Prevalence, Incidence, and Outcome of Non-alcoholic Fatty Liver Disease in Asia, 1999-2019: A Systematic Review and Meta-analysis, Jie Li, Biyao Zou, Yee Hui Yeo, Yuemin Feng, Xiaoyu Xie, Dong Hyun Lee, Hideki Fujii, Yuankai Wu, Leslie Y. Kam, Fanpu Ji, Xiaohe Li, Nicholas Chien, Mike Wei, Eiichi Ogawa, Changqing Zhao, Xia Wu, Christopher D. Stave, Linda Henry, Scott Barnett, Hirokazu Takahashi, Norihiro Furusyo, Yuichiro Eguchi, Yao-Chun Hsu, Teng-Yu Lee, Wanhua Ren, Chengyong Qin, Dae Won Jun, Hidenori Toyoda, Vincent Wai-Sun Wong, Ramsey Cheung, Qiang Zhu, Mindie H. Nguyen, 2019
- Epidemiology of COVID-19: A Systematic Review and Meta-analysis of Clinical Characteristics, Risk factors and Outcomes, Jie Li, Huang DQ, Zou B, Yang H, Hui WZ, Rui F, Yee NTS, Liu C, Nerurkar SN, Kai JCY, Teng MLP, Li X, Zeng H, Borghi JA, Henry L, Cheung R, Nguyen MH, 2021
- Longitudinal proteomic investigation of COVID-19 vaccination, Yingrui Wang, Qianru Zhu, Rui Sun, Xiao Yi, Lingling Huang, Yifan Hu, Weigang Ge, Huanhuan Gao, Xinfu Ye, Yu Song, Li Shao, Yantao Li, Jie Li, Tiannan Guo, Junping Shi, 2023
- Development of a machine learning-based model to predict hepatic inflammation in chronic hepatitis B patients with concurrent hepatic steatosis: a cohort study, Fajuan Rui, Yee Hui Yeo, Liang Xu, Qi Zheng, Xiaoming Xu, Wenjing Ni, Youwen Tan, Qing-lei Zeng, Zebao He, Xiaorong Tian, Qi Xue, Yuanwang Qiu, Chuanwu Zhu, Weimao Ding, Jian Wang, Rui Huang, Yayun Xu, Yunliang Chen, Junqing Fan, Zhiwen Fan, Xiaolong Qi, Daniel Q. Huang, Qing Xie, Junping Shi, Chao Wu, Jie Li, 2023
- Phosphatidic acid-enabled MKL1 contributes to liver regeneration: Translational implication in liver failure, Jiawen Zhou, Xinyue Sun, Xuelian Chen, Huimin Liu, Xiulian Miao, Yan Guo, Zhiwen Fa, Jie Li, Yong Xua, Zilong Li, 2023
- Alcohol Intake Thresholds in Individuals with Steatotic Liver Disease, Yee Hui Yeo, Yixuan Zhu, Juan Pablo Arab, Wenjing Ni, Xiaoming Xu, Junping Shi, Jie Li, 2023
- The Presence of Baseline HBsAb-Specific B Cells Can Predict HBsAg or HBeAg seroconversion of Chronic Hepatitis B on treatment, Yin S, Wan Y, Issa R, Zhu Y, Xu X, Liu J, Mao M, Li M, Tong X, Tian C, Wang J, Huang R, Zhang Q, Wu C, Chen Y, Jie Li, 2023
- The Changing Epidemiology of Liver Disease Among United States Children and Adolescents from 1999-2016, Jie Li, Michael H. Le, Monique T. Barakat, Ramsey C. Cheung, Mindie H. Nguyen, 2021
- Nonalcoholic Fatty Liver Disease in Children: where are we?, Jie Li, Ramsey C. Cheung, 2022
- Chronic Hepatitis B and Steatotic Liver Disease: a Blessing in Disguise?, Xiaoming Xu, Mindie H Nguyen, Jie Li, 2024
- Comment on Cai et al. Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Diabetes Care. 2020; 43:1392-1398 (Letter), Zebaohe, Jie Li, 2020
- Letter to the Editor: Chronic Hepatitis B and Nonalcoholic Steatohepatitis: Is Fat All Bad?, Jie Li, Ramsey C. Cheung, Mindie H. Nguyen, 2020
- Screening for fatty liver disease and fibrosis in the elderly population: A call for action, Jie Li, Mindie H. Nguyen, 2023
- Chronic hepatitis B and fatty liver-weal or woe?, Jie Li, Mindie H. Nguyen, 2022
- A Promising Digital Therapeutics for Nonalcoholic Steatohepatitis: More Efforts Are Needed, Run Zhou, Binbin Zhang, Yunpeng Gu, Jie Li, Junping Shi, 2023
- Inhibition of STAT1 methylation is involved in the resistance of hepatitis B virus to interferon alpha, Jie Li, Feng Chen, Min Zheng, Haihong Zhu, Dongjiu Zhao, Weixia Liu, Wei Liu, Chen zhi, 2010
- Circulating Th2-biased T follicular helper cells impede antiviral humoral responses during chronic hepatitis B infection through upregulating CTLA4, Yin S, Wang J, Chen L, Mao M, Rahma I, Geng Y, Huang R, Tong X, Liu Y, Wu C, Chen Y, Jie Li, 2023
- C-C motif chemokine CCL11 is a novel regulator and a potential therapeutic target in non-alcoholic fatty liver disease, Zhiwen Fan, Xinyue Sun, Xuelian Chen, Huimin Liu, Xiulian Miao, Yan Guo, Yong Xu, Jie Li, Xiaoping Zou, Zilong Li, 2023
- Meta-analysis: global prevalence, trend and forecasting of non-alcoholic fatty liver disease in children and adolescents, 2000-2021, Jie Li, Ha Audrey, Rui Fajuan, Zou Biyao, Yang Hongli, Xue Qi, Hu Xinyu, Xu Yayun, Henry Linda, Barakhat Monique, Stave Christopher, Shi Jun-Ping, Wu Chao, Cheung Ramsey, Mindie H. Nguyen, 2022
- Letter: to expand the diagnosis and scale up treatment for patients with chronic hepatitis B-difficult but necessary, Xu X, Liu J, Wu C, Jie Li, 2023
- Fatty liver is not independently associated with rates of complete response to oral antiviral therapy in chronic hepatitis B patients, Jie Li, An K. Le, Kevin T. Chaung, Linda Henry, Joseph K. Hoang, Ramsey Cheung, Mindie H. Nguyen, 2020
- The role of interleukin-27 in predicting spontaneous HBeAg seroconversion in chronic hepatitis B infection, Jie Li, Lung Yi Mak, Danny Wong, James Y. Y. Fung, Wai-Kay Seto, Ching Lung Lai, Man Fung Yuen, 2017
- Non-alcoholic fatty liver disease (NAFLD) in Asia-More efforts are needed, Jie Li, Mindie H. Nguyen, 2020
- Noninvasive diagnosis methods are needed in paediatric non-alcoholic fatty liver disease (NAFLD), Jie Li, Mindie H. Nguyen, 2021
- Association between fatty liver and cirrhosis, hepatocellular carcinoma, and HBsAg seroclearance in chronic hepatitis B, Jie Li, Hwai-I Yang, Ming-Lun Yeh, An K. Le, Yee Hui Yeo, Chia-Yen Dai, Scott Barnett, Jian Q. Zhang, Jee-Fu Huang, Huy N. Trinh, Christopher Wong, Clifford Wong, Joseph K. Hoang, Ramsey Cheung, Ming-Lung Yu, Mindie H. Nguyen, 2021
- The impact of an increased Fibrosis-4 index and the severity of hepatic steatosis on mortality in diabetes patients, Xiaoyan Ma, Yixuan Zhu, Yee Hui Yeo, Zhiwen Fan, Xiaoming Xu, Fajuan Rui, Wenjing Ni, Qi Gu, Xin Tong, Shengxia Yin, Xiaolong Qi, Junping Shi, Chao Wu, Jie Li, 2023
- Serum metabolomics-based heterogeneities and screening strategy for metabolic dysfunction-associated fatty liver disease (MAFLD), Shao L, Liu J, Song Y, Yang W, Gong L, Lyu Z, Zhu Q, Fu J, Jie Li, Shi J, 2023
- Clinical impact and mechanisms of hepatitis B virus infection concurrent with non-alcoholic fatty liver disease, Xin Tong, Shengxia Yin, Jian Wang, Rui Huang, Chao Wu, Jun ping Shi, Jie Li, 2022
- Diagnosis and assessment of disease severity in patients with Nonalcoholic Fatty Liver Disease, Jie Li, Adèle Delamarre, Vincent Wai-Sun Wong, Victor de Lédinghen, 2023
- Clinical characteristics and possible etiology in children with acute severe hepatitis of unknown etiology, Jie Li, Xinyu Hu, Xuein Yan, Wu C, Yuemin Nan, 2022
- Interaction between the Mucus Layer and the Gut Microbiota in NAFLD: Soil and Seeds, Binbin Zhang, Jie Li, Jinlong Fu, Luping Yang, Junping Shi, 2023
- HBcAg induces Interleukin 10 production, inhibiting HBcAg-specific Th17 responses in chronic hepatitis B patients, Jie Li, Wei Wu, Guoping Peng, Feng Chen, Minghui Bai, Min Zheng and Zhi Chen, 2010
- Noninvasive diagnosis of significant liver inflammation in patients with chronic hepatitis B in the indeterminate phase, Zhan J, Wang J, Zhang Z, Xue R, Jiang S, Liu J, Liu Y, Zhu L, Xia J, Yan X, Ding W, Zhu C, Qiu Y, Jie Li, Huang R, Wu C, 2023
- Characteristics and mechanism of liver injury in 2019
Awards
- 2018 - Shandong Medical Science and Technology Award Second Prize (1/7)
- 2017 - Shandong Science and Technology Progress Award Second Prize (3/8)
- 2018 - Shandong Higher Education Science and Technology Award First Prize (4/8)
- 2019 - Huaxia Medical Science and Technology Award Third Prize (3/9)
- 2023 - Jiangsu Medical Science and Technology Award Second Prize (1/9)
